Richard Salzman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard Salzman has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Ivo Stárek
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
5 shared publicationsIvo Starek
Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, I. P. Pavlova 185/6, Olomouc 779 00, Czech Republic
4 shared publicationsI. Stárek
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacký University Olomouc, I.P. Pavlova 6, 77900 Olomouc, Czech Republic
3 shared publications- Zuzana Horakova
Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, I. P. Pavlova 185/6, Olomouc 779 00, Czech Republic
3 shared publications - Zuzana Sedlackova
Comprehensive Stroke Center, Department of Radiology, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic
3 shared publications A. Skálová
Department of Pathology, Charles University in Prague, Alej svobody 80, 304 60, Pilsen, Czech Republic
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Tsinghua University Press in Journal of Otology
- Vol. 21 (3) , 136-151
Usefulness of 99m Tc-HMPAO leukocyte scintigraphy in necrotizing external otitis/skull base osteomyelitis
Necrotizing external otitis (NEO) is a rare but serious disease of the skull base (osteomyelitis). Immunosuppressed, and elderly patients are most commonly affected. The most common pathogen is Pseudomonas aeruginosa. Early diagnosis is crucial for the prognosis. To establish the diagnosis, both positive imaging findings, and clinical criteria are required to be met. Imaging is used during follow-up to monitor a potential recurrence due to its high risk, even after successful treatment. The use of radiological or nuclear medicine methods (scintigraphy) in the management of NEO is not currently standardised. We report a series of 5 patients with necrotizing external otitis/otogenic skull base osteomyelitis over a period of 12 years (2012-2024). In all patients, 99mTc-HMPAO (hexa-methyl-propylene-amine-oxime) labelled autologous leukocyte scintigraphy was used to diagnose, to monitor therapy response and for a follow-up. The primary diagnosis of necrotizing otitis was confirmed by scintigraphy in all cases (positive predictive value of 100%). In monitoring of treatment response, true negative scintigraphic findings were observed in two cases, two findings were false-negative (negative predictive value of 50%), and one case was found to be a false-positive. In a follow-up, the recurrence of the disease was truly detected or ruled out by subsequent scintigraphy in all subjects. Technetium-99m-labelled leukocyte scintigraphy is a convenient and reliable method, especially for diagnosing, and follow-up of necrotizing external otitis/otogenic skull base osteomyelitis. In terms of monitoring treatment response, further studies could be suggested for improving the estimated low negative predictive value.
- 1 July 2026
- Published by Tsinghua University Press in Journal of Otology
- Vol. 21 (3) , 136-151
Open AccessUsefulness of 99m Tc-HMPAO leukocyte scintigraphy in necrotizing external otitis/skull base osteomyelitis
Necrotizing external otitis (NEO) is a rare but serious disease of the skull base (osteomyelitis). Immunosuppressed, and elderly patients are most commonly affected. The most common pathogen is Pseudomonas aeruginosa. Early diagnosis is crucial for the prognosis. To establish the diagnosis, both positive imaging findings, and clinical criteria are required to be met. Imaging is used during follow-up to monitor a potential recurrence due to its high risk, even after successful treatment. The use of radiological or nuclear medicine methods (scintigraphy) in the management of NEO is not currently standardised. We report a series of 5 patients with necrotizing external otitis/otogenic skull base osteomyelitis over a period of 12 years (2012-2024). In all patients, 99mTc-HMPAO (hexa-methyl-propylene-amine-oxime) labelled autologous leukocyte scintigraphy was used to diagnose, to monitor therapy response and for a follow-up. The primary diagnosis of necrotizing otitis was confirmed by scintigraphy in all cases (positive predictive value of 100%). In monitoring of treatment response, true negative scintigraphic findings were observed in two cases, two findings were false-negative (negative predictive value of 50%), and one case was found to be a false-positive. In a follow-up, the recurrence of the disease was truly detected or ruled out by subsequent scintigraphy in all subjects. Technetium-99m-labelled leukocyte scintigraphy is a convenient and reliable method, especially for diagnosing, and follow-up of necrotizing external otitis/otogenic skull base osteomyelitis. In terms of monitoring treatment response, further studies could be suggested for improving the estimated low negative predictive value.
- Open Access
- 26 February 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (4) , 1640-1650
Preoperative CT Predictors for Thyroid Gland Tumour Involvement in Laryngeal Carcinoma
Objective: The aim of our study is to assess the role of preoperative computed tomography (CT) in determining the risk of thyroid gland invasion (TGI) in advanced laryngeal carcinoma. Background: Thyroidectomy is generally recommended in patients undergoing total laryngectomy (TLE) for advanced laryngeal cancer. Methods: In a retrospective analysis of 61 patients after TLE with thyroidectomy, we evaluated the predictive value of preoperative CT scan parameters for TGI. Results: In all 5 cases of TGI (8%), the adjacent lobe of the thyroid gland was involved. The statistically significant risk parameters were tumour subglottic extension exceeding 15 mm ( p = 0.039), cricoid cartilage chondrolysis ( p = 0.01), and cricothyroid membrane invasion ( p = 0.007) on CT scans. Both cricoid cartilage chondrolysis and cricothyroid membrane invasion were also identified as independent predictors for TGI (OD 18, p = 0.028 and OD 20, p = 0.02) through regression analysis. Conclusion: Given the low incidence of occult TGI, we do not believe that routine elective thyroidectomy to be justified. In an elective setting, a hemithyroidectomy is sufficient and should be considered for tumours exhibiting subglottic extension and/or signs of thyroid or cricoid cartilage chondrolysis, or infiltration of the cricothyroid membrane on preoperative CT scans.
- 26 February 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (4) , 1640-1650
Open AccessPreoperative CT Predictors for Thyroid Gland Tumour Involvement in Laryngeal Carcinoma
Objective: The aim of our study is to assess the role of preoperative computed tomography (CT) in determining the risk of thyroid gland invasion (TGI) in advanced laryngeal carcinoma. Background: Thyroidectomy is generally recommended in patients undergoing total laryngectomy (TLE) for advanced laryngeal cancer. Methods: In a retrospective analysis of 61 patients after TLE with thyroidectomy, we evaluated the predictive value of preoperative CT scan parameters for TGI. Results: In all 5 cases of TGI (8%), the adjacent lobe of the thyroid gland was involved. The statistically significant risk parameters were tumour subglottic extension exceeding 15 mm ( p = 0.039), cricoid cartilage chondrolysis ( p = 0.01), and cricothyroid membrane invasion ( p = 0.007) on CT scans. Both cricoid cartilage chondrolysis and cricothyroid membrane invasion were also identified as independent predictors for TGI (OD 18, p = 0.028 and OD 20, p = 0.02) through regression analysis. Conclusion: Given the low incidence of occult TGI, we do not believe that routine elective thyroidectomy to be justified. In an elective setting, a hemithyroidectomy is sufficient and should be considered for tumours exhibiting subglottic extension and/or signs of thyroid or cricoid cartilage chondrolysis, or infiltration of the cricothyroid membrane on preoperative CT scans.
- 4 November 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (12) , 3608-3623
Cyfra 21-1 and SCC Ag, Useful Oncomarkers in Head and Neck Cancer
- 4 November 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (12) , 3608-3623
Cyfra 21-1 and SCC Ag, Useful Oncomarkers in Head and Neck Cancer
- Open Access
- 13 May 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (6) , 1092-1102
Predictors of Thyroid Gland Invasion in Advanced Laryngeal Carcinoma: When is an Elective Thyroidectomy Indicated?
Objective: The aim of our study was to evaluate the incidence of occult laryngeal tumor invasion into the thyroid gland and to determine the role of preoperative clinical parameters in predicting the risk of thyroid gland involvement (TGI). Background: Generally, thyroidectomy is recommended for nearly all patients undergoing total laryngectomy (TLE) for the treatment of advanced laryngeal cancer, but the procedure is related to increased post-treatment morbidity. Methods: In a retrospective analysis of 61 patients after TLE with thyroidectomy, we monitored the incidence of TGI and its relationship with clinical and histological parameters. Results: We identified 8% of patients with TGI. The statistically significant risk parameters for TGI were T4 stage (p=0.023) and full-thickness thyroid cartilage chondrolysis (p=0.044); subglottic tumor growth was nearly significant (p=0.15). Elective thyroidectomy was associated with a lower recurrence rate, both locoregional and distant (6 vs.32). Conclusion: Routinely performed elective thyroidectomy during TLE is not necessary because the incidence of occult TGI is low. In the elective setting, hemithyroidectomy is sufficient and should be indicated for T4 and selected T3 tumors in which it brings a prognostic benefit.
- 13 May 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (6) , 1092-1102
Open AccessPredictors of Thyroid Gland Invasion in Advanced Laryngeal Carcinoma: When is an Elective Thyroidectomy Indicated?
Objective: The aim of our study was to evaluate the incidence of occult laryngeal tumor invasion into the thyroid gland and to determine the role of preoperative clinical parameters in predicting the risk of thyroid gland involvement (TGI). Background: Generally, thyroidectomy is recommended for nearly all patients undergoing total laryngectomy (TLE) for the treatment of advanced laryngeal cancer, but the procedure is related to increased post-treatment morbidity. Methods: In a retrospective analysis of 61 patients after TLE with thyroidectomy, we monitored the incidence of TGI and its relationship with clinical and histological parameters. Results: We identified 8% of patients with TGI. The statistically significant risk parameters for TGI were T4 stage (p=0.023) and full-thickness thyroid cartilage chondrolysis (p=0.044); subglottic tumor growth was nearly significant (p=0.15). Elective thyroidectomy was associated with a lower recurrence rate, both locoregional and distant (6 vs.32). Conclusion: Routinely performed elective thyroidectomy during TLE is not necessary because the incidence of occult TGI is low. In the elective setting, hemithyroidectomy is sufficient and should be indicated for T4 and selected T3 tumors in which it brings a prognostic benefit.
- Open Access
- 8 March 2024
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 2024, 1-12
Tumour Recurrence, Depth of Invasion, and Temple Location as Independent Prognostic Parameters of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinomas
The excellent survival rate of cutaneous squamous cell carcinoma (cSCC) exceeding 90 is reduced by the presence of nodal metastases by over 50. We analysed various risk parameters of cSCC to predict the incidence of nodal metastases. A total of 118 patients with the head cSCC were included in a single-institution retrospective study covering the period from 2008 to 2020. Tumour recurrence, temple location, and tumour infiltration depth were found to be independent predictors of nodal metastases (increasing the probability of metastases by 8.0, 8.1, and 4.3 times, respectively). Furthermore, univariate analysis shows that the tumour size and T stage are significant factors increasing the risk of metastases. Several independent risk factors for the development of metastases in the head cSCC have been confirmed. These findings might help identify at-risk patients who require additional attention for adequate radical treatment and close follow-up. In contrast, elective treatment of lymph nodes is not recommended due to the low incidence of regional metastases.
- 8 March 2024
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 2024, 1-12
Open AccessTumour Recurrence, Depth of Invasion, and Temple Location as Independent Prognostic Parameters of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinomas
The excellent survival rate of cutaneous squamous cell carcinoma (cSCC) exceeding 90 is reduced by the presence of nodal metastases by over 50. We analysed various risk parameters of cSCC to predict the incidence of nodal metastases. A total of 118 patients with the head cSCC were included in a single-institution retrospective study covering the period from 2008 to 2020. Tumour recurrence, temple location, and tumour infiltration depth were found to be independent predictors of nodal metastases (increasing the probability of metastases by 8.0, 8.1, and 4.3 times, respectively). Furthermore, univariate analysis shows that the tumour size and T stage are significant factors increasing the risk of metastases. Several independent risk factors for the development of metastases in the head cSCC have been confirmed. These findings might help identify at-risk patients who require additional attention for adequate radical treatment and close follow-up. In contrast, elective treatment of lymph nodes is not recommended due to the low incidence of regional metastases.
- Open Access
- 19 February 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024, 1-10
Parotid Gland Metastases of Cutaneous Squamous Cell Carcinoma of the Head: Occult Metastases Occurrence and Their Late Manifestation
Cutaneous squamous cell carcinomas (cSCC) are malignant tumours with excellent prognosis unless nodal metastases develop. The aim of our study is to determine the prognostic significance of the clinical stage of parotid gland metastases and the incidence of occult cervical lymph node involvement in cSCC of the head. Our retrospective analysis includes 39 patients with cSCC parotid gland metastases, 15 of whom had concurrent cervical node involvement. In 32 patients, the lymph nodes manifested at stage N3b. A total of 26 patients were treated with parotidectomy, 9 patients received radiotherapy alone, and 4 received symptomatic therapy. The surgical treatment included either total conservative (21 cases) or superficial parotidectomy (5 cases) and neck dissection (therapeutic neck dissections in 11 cases and elective in 14 cases). In all cases, surgery was performed with sufficient tumour-free resection margins. Adjuvant radiotherapy was administered postoperatively in 16 patients. Occult metastases were present in 21% of cases after an elective neck dissection, but not in any case in the deep lobe of the parotid gland. The five-year overall survival and recurrence-free interval were 52% and 55%, respectively. Patients with the cN3b stage and G3 histological grade tend to have a worse prognosis, but not at a statistically significant level. The prognosis was not worse in patients with concurrent parotid and cervical metastases compared to those with metastases limited to the parotid gland only. The addition of adjuvant irradiation, in comparison to a single modality surgical treatment, was the only statistically significant prognostic factor that reduced the risk of death from this diagnosis ( ). The extent of parotidectomy (partial vs. total) had no impact on either the risk of recurrence or patient prognosis. The combination of surgery with irradiation provides the best results and should be applied to all patients who tolerate the treatment. A partial superficial parotidectomy should be sufficient, with a minimum risk of occult metastasis in the deep lobe. Conversely, the relatively high incidence of occult neck metastases indicates that patients could likely benefit from elective neck dissection.
- 19 February 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024, 1-10
Open AccessParotid Gland Metastases of Cutaneous Squamous Cell Carcinoma of the Head: Occult Metastases Occurrence and Their Late Manifestation
Cutaneous squamous cell carcinomas (cSCC) are malignant tumours with excellent prognosis unless nodal metastases develop. The aim of our study is to determine the prognostic significance of the clinical stage of parotid gland metastases and the incidence of occult cervical lymph node involvement in cSCC of the head. Our retrospective analysis includes 39 patients with cSCC parotid gland metastases, 15 of whom had concurrent cervical node involvement. In 32 patients, the lymph nodes manifested at stage N3b. A total of 26 patients were treated with parotidectomy, 9 patients received radiotherapy alone, and 4 received symptomatic therapy. The surgical treatment included either total conservative (21 cases) or superficial parotidectomy (5 cases) and neck dissection (therapeutic neck dissections in 11 cases and elective in 14 cases). In all cases, surgery was performed with sufficient tumour-free resection margins. Adjuvant radiotherapy was administered postoperatively in 16 patients. Occult metastases were present in 21% of cases after an elective neck dissection, but not in any case in the deep lobe of the parotid gland. The five-year overall survival and recurrence-free interval were 52% and 55%, respectively. Patients with the cN3b stage and G3 histological grade tend to have a worse prognosis, but not at a statistically significant level. The prognosis was not worse in patients with concurrent parotid and cervical metastases compared to those with metastases limited to the parotid gland only. The addition of adjuvant irradiation, in comparison to a single modality surgical treatment, was the only statistically significant prognostic factor that reduced the risk of death from this diagnosis ( ). The extent of parotidectomy (partial vs. total) had no impact on either the risk of recurrence or patient prognosis. The combination of surgery with irradiation provides the best results and should be applied to all patients who tolerate the treatment. A partial superficial parotidectomy should be sufficient, with a minimum risk of occult metastasis in the deep lobe. Conversely, the relatively high incidence of occult neck metastases indicates that patients could likely benefit from elective neck dissection.
- 26 January 2024
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (3) , 104226
Comparison of capabilities and limitations of endoscopes in endoscopic ear surgeries using 3D printed models
- 26 January 2024
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (3) , 104226
Comparison of capabilities and limitations of endoscopes in endoscopic ear surgeries using 3D printed models
- Open Access
- 25 December 2023
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 38 (1) , 358-364
Primary Squamous Cell Carcinoma of the Parotid Gland: Study and Review of the Literature
Background/Aim: Primary squamous cell carcinoma of the parotid gland (pPSCC) is a rare tumor, accounting for less than 3% of all parotid carcinomas. There is no general consensus on the management of this tumor, since clinical experience for pPSCC is minimal. Moreover, pPSCC is often misdiagnosed for metastatic cutaneous carcinoma. In our study, we focused on evaluating its biological and clinical characteristics, treatment results and prognosis. We proposed an update on diagnostic and therapeutic management of pPSCC. Patients and Methods: The retrospective cohort included 18 patients diagnosed and treated for pPSCC in three tertiary head and neck centers between 2008 and 2022. We retrospectively evaluated their prognosis and established a therapeutic recommendation after analyzing our own and previously published data. Results: Fourteen of 18 tumors were diagnosed in stage IV. Five-year overall survival was 36 months. Six patients received palliative therapy. Twelve patients underwent parotidectomy, neck dissection, and adjuvant radiotherapy. Remission was achieved in 8 patients (follow-up interval 3-56 months). One patient died with recurrent disease. The others are alive and in complete remission. Conclusion: The definitive diagnosis of pPSCC must meet the histological and clinical criteria. First of all, the metastatic origin of the tumor must be excluded. Five-year survival of this very aggressive tumor does not exceed 50%. Without surgery, the prognosis is poor. The best results, irrespective of tumor stage, are achieved with surgery. Therefore, a total parotidectomy, neck dissection (therapeutic or elective) and adjuvant radiotherapy are indicated for all resectable tumors.
- 25 December 2023
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 38 (1) , 358-364
Open AccessPrimary Squamous Cell Carcinoma of the Parotid Gland: Study and Review of the Literature
Background/Aim: Primary squamous cell carcinoma of the parotid gland (pPSCC) is a rare tumor, accounting for less than 3% of all parotid carcinomas. There is no general consensus on the management of this tumor, since clinical experience for pPSCC is minimal. Moreover, pPSCC is often misdiagnosed for metastatic cutaneous carcinoma. In our study, we focused on evaluating its biological and clinical characteristics, treatment results and prognosis. We proposed an update on diagnostic and therapeutic management of pPSCC. Patients and Methods: The retrospective cohort included 18 patients diagnosed and treated for pPSCC in three tertiary head and neck centers between 2008 and 2022. We retrospectively evaluated their prognosis and established a therapeutic recommendation after analyzing our own and previously published data. Results: Fourteen of 18 tumors were diagnosed in stage IV. Five-year overall survival was 36 months. Six patients received palliative therapy. Twelve patients underwent parotidectomy, neck dissection, and adjuvant radiotherapy. Remission was achieved in 8 patients (follow-up interval 3-56 months). One patient died with recurrent disease. The others are alive and in complete remission. Conclusion: The definitive diagnosis of pPSCC must meet the histological and clinical criteria. First of all, the metastatic origin of the tumor must be excluded. Five-year survival of this very aggressive tumor does not exceed 50%. Without surgery, the prognosis is poor. The best results, irrespective of tumor stage, are achieved with surgery. Therefore, a total parotidectomy, neck dissection (therapeutic or elective) and adjuvant radiotherapy are indicated for all resectable tumors.
- Open Access
- 4 December 2023
- Published by Palacky University Olomouc in Biomedical Papers
- Vol. 167 (4) , 319-327
Current status and future perspectives of oral HPV testing in the diagnosis and monitoring of oropharyngeal cancer. A review
HPV16 status in oropharyngeal cancer (OPC) is an important prognostic factor. Its determination, based on immunistochemical analysis of p16 oncoprotein requires an invasive biopsy. Thus, alternative methods are being sought. Determining oral HPV16 status appears to be a promising alternative. However, it is not used routinely. This prompted us to perform a systematic literature review enabling us to evaluate the diagnostic and predictive ability of this approach. Thirty-four relevant studies were finally selected. For determination of HPV status in OPC, the calculated average sensitivity and specificity for oral sampling was 74% and 91%, respectively, with p16 tumour tissue marker being the gold standard. The method appears to be valuable in monitoring treatment response as well as the biological activity of the tumour, enabling early detection of persistent or relapsing carcinoma sufficiently long before its clinical and/or radiological manifestation. It can also contribute to identification of the primary tumour in cases of metastases of unknown origin. Last but not least, the screening HPV oral testing would help to identify individuals with persistent HPV oral infection who are at increased risk of development of OPC.
- 4 December 2023
- Published by Palacky University Olomouc in Biomedical Papers
- Vol. 167 (4) , 319-327
Open AccessCurrent status and future perspectives of oral HPV testing in the diagnosis and monitoring of oropharyngeal cancer. A review
HPV16 status in oropharyngeal cancer (OPC) is an important prognostic factor. Its determination, based on immunistochemical analysis of p16 oncoprotein requires an invasive biopsy. Thus, alternative methods are being sought. Determining oral HPV16 status appears to be a promising alternative. However, it is not used routinely. This prompted us to perform a systematic literature review enabling us to evaluate the diagnostic and predictive ability of this approach. Thirty-four relevant studies were finally selected. For determination of HPV status in OPC, the calculated average sensitivity and specificity for oral sampling was 74% and 91%, respectively, with p16 tumour tissue marker being the gold standard. The method appears to be valuable in monitoring treatment response as well as the biological activity of the tumour, enabling early detection of persistent or relapsing carcinoma sufficiently long before its clinical and/or radiological manifestation. It can also contribute to identification of the primary tumour in cases of metastases of unknown origin. Last but not least, the screening HPV oral testing would help to identify individuals with persistent HPV oral infection who are at increased risk of development of OPC.
- Open Access
- 23 October 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 90 (1) , 101352
Elective parotidectomy and neck dissection are not beneficial in cutaneous squamous cell carcinoma of the head
- 23 October 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 90 (1) , 101352
Open AccessElective parotidectomy and neck dissection are not beneficial in cutaneous squamous cell carcinoma of the head